Dermatology NewsSelf-injectable belimumab receives FDA approval for systemic lupus erythematosusJuly 21, 2017Autoimmune Diseases
Dermatology NewsNew classification system for systemic lupus erythematosus moves forwardJuly 20, 2017Autoimmune Diseases
Dermatology NewsTWEAKing inflammation: Studies reflect potential treatment target for psoriasis, atopic dermatitisJune 28, 2017Autoimmune DiseasesPsoriasisAtopic Dermatitis
Dermatology NewsVIDEO: Troponin acts as atherosclerotic biomarker in patients with lupusJune 16, 2017Autoimmune Diseases
Dermatology NewsCC-220 shows efficacy, safety concerns in phase II SLE trialMay 15, 2017Autoimmune DiseasesMedical Dermatology
Dermatology NewsSLE linked to subsequent risk of malignant melanomaMay 11, 2017Autoimmune DiseasesMelanoma
Dermatology NewsCutaneous manifestations can signify severe systemic disease in ANCA-associated vasculitisMay 9, 2017Autoimmune Diseases
Dermatology NewsJAK inhibitors and alopecia: After positive early data, various trials now underwayMay 8, 2017Hair & NailsAutoimmune Diseases
Dermatology NewsFDA grants breakthrough therapy status to rituximab for pemphigus vulgarisMarch 29, 2017Autoimmune DiseasesWounds
Dermatology NewsVIDEO: Don’t overlook psychosocial concerns of vitiligo patientsMarch 5, 2017Autoimmune DiseasesPediatrics
Dermatology NewsFor bullous pemphigoid, doxycycline noninferior to prednisolone, but saferMarch 4, 2017Autoimmune Diseases
Dermatology NewsConnective tissue diseases reported in patients receiving immune checkpoint inhibitorsMarch 3, 2017MelanomaAutoimmune Diseases
Dermatology NewsPediatric lupus patients face large burden of serious infectionFebruary 27, 2017PediatricsRare DiseasesAutoimmune Diseases